A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells

Tyrosine Kinase ◽

Hdac Inhibitor ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells

ABT-737 increases tyrosine kinase inhibitor–induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38− population to imatinib

Experimental Hematology ◽

10.1016/j.exphem.2012.01.004 ◽

2012 ◽

Vol 40 (5) ◽

pp. 367-378.e2 ◽

Cited By ~ 23

Author(s):

Kelly Airiau ◽

François-Xavier Mahon ◽

Marina Josselin ◽

Marie Jeanneteau ◽

Beatrice Turcq ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells ◽

Induced Apoptosis

AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitor‑sensitive and ‑resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora�B

Oncology Reports ◽

10.3892/or.2020.7739 ◽

2020 ◽

Author(s):

Tomoya Takeda ◽

Masanobu Tsubaki ◽

Shuji Genno ◽

Chisato Nemoto ◽

Yasuka Onishi ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Antiproliferative Effect ◽

Leukemia Cells ◽

Aurora B ◽

Aurora A

Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells

Applied Microbiology and Biotechnology ◽

10.1007/s00253-014-6003-1 ◽

2014 ◽

Vol 98 (23) ◽

pp. 9763-9775 ◽

Cited By ~ 4

Author(s):

Jiajun Fan ◽

Xiaochun Dong ◽

Weixing Zhang ◽

Xian Zeng ◽

Yubin Li ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells

ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells

Stem Cell Reports ◽

10.1016/j.stemcr.2018.01.015 ◽

2018 ◽

Vol 10 (3) ◽

pp. 1115-1130 ◽

Cited By ~ 14

Author(s):

Masashi Miyauchi ◽

Junji Koya ◽

Shunya Arai ◽

Sho Yamazaki ◽

Akira Honda ◽

...

Keyword(s):

Stem Cells ◽

Tyrosine Kinase ◽

Induced Pluripotent Stem Cells ◽

Pluripotent Stem Cells ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells ◽

Induced Pluripotent

BCR-AblSilencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy

Stem Cells and Development ◽

10.1089/scd.2018.0196 ◽

2019 ◽

Vol 28 (11) ◽

pp. 734-744 ◽

Cited By ~ 4

Author(s):

Remant KC ◽

Bindu Thapa ◽

Anyeld Ubeda ◽

Xiaoyan Jiang ◽

Hasan Uludağ

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Leukemia Cells ◽

Tyrosine Kinase Inhibitor Therapy

Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells

Oncotarget ◽

10.18632/oncotarget.16314 ◽

2017 ◽

Vol 8 (24) ◽

pp. 38717-38730 ◽

Cited By ~ 10

Author(s):

Masanobu Tsubaki ◽

Tomoya Takeda ◽

Toshiki Kino ◽

Kazuko Sakai ◽

Tatsuki Itoh ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells ◽

Inhibitor Resistance

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells

Cell Communication and Signaling ◽

10.1186/s12964-016-0129-y ◽

2016 ◽

Vol 14 (1) ◽

Cited By ~ 9

Author(s):

Sebastian Halbach ◽

Zehan Hu ◽

Christine Gretzmeier ◽

Julia Ellermann ◽

Franziska U. Wöhrle ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Leukemia Cells

17 / An Observational Study of Survival in Patients With Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)

10.26226/morressier.5b3b802cb1b87b000eced8f4 ◽

2018 ◽

Author(s):

Mauro Michael J.

Keyword(s):

Observational Study ◽

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Chronic Phase

08 / Caring for Patients With Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitor (TKI) Therapy in an Era of Evolving Treatment Goals

10.26226/morressier.5b3b802cb1b87b000eced8ee ◽

2018 ◽

Author(s):

Nodzon Lisa A.

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor ◽

Treatment Goals

Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era

Current Cancer Drug Targets ◽

10.2174/15680096113139990090 ◽

2013 ◽

Vol 13 (7) ◽

pp. 755-767 ◽

Cited By ~ 8

Author(s):

Domenico Russo ◽

Michele Malagola ◽

Cristina Skert ◽

Carla Filì ◽

Cesare Bergonzi ◽

...

Keyword(s):

Elderly Patients ◽

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Kinase Inhibitor